Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

Posted:
3
February 2021

Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London

Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London. As one of the largest independent clinical research organisations in the UK, Richmond Pharmacology has the expertise and equipment to adapt its London Bridge facility to administer vaccines for many residents in Southwark and the surrounding areas.  


Neil Coyle MP for Southwark and Old Borough outlines why this is important in his interview with BBC Politics London.


Richmond Pharmacology has been supporting the local community throughout the pandemic by providing rapid COVID tests to a local primary school, church, and synagogue. Assistance was also offered to staff at nearby businesses and hospitals when testing for the virus was not easily accessible.


Keith Berelowitz, Director of Operations at Richmond Pharmacology, said: “At what could be a pivotal moment during this pandemic, we must all do what we can to expedite the rollout of the vaccine in our local communities. We recognise that Richmond Pharmacology has the skills and facilities to support the Government in ensuring that the most vulnerable in our society are protected as soon as possible.”


Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more